Supplementary Figure S1 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models | Synapse
June 5, 2024Open Access
Supplementary Figure S1 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models
Key Points
Key points are not available for this paper at this time.
Abstract
Tumor growth response of TNBC PDX models to eribulin monotherapy